Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Approval Study to Evaluate the Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System Used Non-adjunctively

NCT04836546 is registered in ClinicalTrials.gov with Senseonics, Inc. as lead sponsor.

NCT NCT04836546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04836546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Approval Study to Evaluate the Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System Used Non-adjunctively
Lead sponsor
Senseonics, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 13, 2021
Completion date
March 31, 2026
Enrollment
925 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes